Procedures, dossier requirements, pharmacovigilance, policy
Marketing authorisation, reporting adverse events, production, distribution
Objectives, decision-making, cooperation, vacancies, contact
16-10-2018 | 16:00
Requests for withdrawal on December 31st (the year-end withdrawals) should be received by the Medicines Evaluation Board (MEB) on ...
14-09-2018 | 12:00
The Medicines Evaluation Board (MEB) intends to intensify collaboration with its partner authority in Switzerland in the field of ...
06-09-2018 | 16:00
The United Kingdom (UK) is leaving the European Union in March 2019. The terms on which the UK is going to leave the EU are still ...
19-07-2018 | 16:00
The 5th issue of the Medicines Evaluation Board’s Regulatory Science Magazine is now available. This issue focuses on ...
13-07-2018 | 08:00
Update for marketing authorisation holders The Falsified Medicines Directive (FMD) (Directive 2011/62/EU) are measures to prevent ...
15-06-2018 | 11:00
Review of 2018 MEB Day Innovation and quick and careful registration. How do we make sure that regulations do not get too much in ...
